DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Revlimid (Lenalidomide) - News


News related to Revlimid (Lenalidomide) and/or conditions it is approved for

Phase III FIRST trial results of REVLIMID® Plus Dexamethasone in newly diagnosed multiple myeloma patients published
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2014.09.08]
Celgene Corporation has announced that data from FIRST (MM-020/IFM 07-01) - an open-label phase III randomized study of continuous REVLIMID (lenalidomide) in combination with dexamethasone in...

Multiple Myeloma
Source: MedicineNet thalidomide Specialty [2013.09.17]
Title: Multiple Myeloma
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 9/17/2013 12:00:00 AM

Kyprolis Approved for Multiple Myeloma
Source: MedicineNet thalidomide Specialty [2012.07.23]
Title: Kyprolis Approved for Multiple Myeloma
Category: Health News
Created: 7/20/2012 4:05:00 PM
Last Editorial Review: 7/23/2012 12:00:00 AM

OncoBriefs: New Myeloma Standard? Robotics and Pain (CME/CE)
Source: MedPage Today Oncology/Hematology [2014.09.12]
(MedPage Today) -- Patients with newly diagnosed multiple myeloma lived longer and had significantly slower disease progression with a new two-drug regimen than with a long-time, standard three-drug regimen, a randomized trial showed.

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014